Tirzepatide

Dual GIP and GLP-1 receptor agonist

99.50% HPLC-MSBatch PH-4220 In stock

$120per 10 mg vial

Vial strength

View purity report (COA)Ships in 1 business day

Single acylated peptide agonist at GIPR and GLP-1R, improving glucose-dependent insulin secretion, reducing appetite and energy intake, and producing substantial weight loss. Receptor balance differs from endogenous…

Specifications

Compound class: Dual GIP and GLP-1 receptor agonist
Sequence: Engineered 39-aa GIP-based peptide
Chain length: 39 aa
Physical form: Lyophilized powder
Modifications: Aib residues and C20 fatty-diacid side chain for albumin binding
Reported half-life: Approximately 5 days
Verified purity: 99.50% (HPLC-MS)
Evidence grade: E1 — Established clinical evidence

Read the full monograph in the Peptide Atlas

Research use only. All products sold on this website are intended for laboratory research and in-vitro experimentation only. They are not drugs, foods, cosmetics, or medical devices, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this site should be construed as medical advice, dosing, or administration guidance. Purchasers must be qualified researchers or institutions and are solely responsible for lawful handling and use.